Vasogen, Inc.

4 Robert Speck Parkway 15th Floor,
Mississauga, Ontario ON L4Z 1S1
Canada,
(905) 817-2000

Vasogen, Inc. is a biotechnology company focused on destructive inflammatory processes associated with the development and progression of cardiovascular and neuro-inflammatory disorders.

Vasogen was acquired by IntelliPharmaCeutics International on October 22, 2009.

Join Mergr to view all 111 acquisitions of life science companies in 2009, including 13 acquisitions by private equity firms, and 98 by strategics.

Out of 60 sectors in the Mergr database, life science ranked 6 in number of deals in 2009. The largest life science acquisition in 2009 was Wyeth - which was acquired by Pfizer for $68.0B.

Join Mergr to view this profile - and discover more life science acquisitions of companies like Vasogen.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.5K Private Equity Firms
  • 123K M&A Transactions
  • 132K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.9K M&A Advisors
    (Investment Banks and Law Firms)
  • 35K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.